MultiPark: Multidisciplinary research focused on Parkinson´s disease

Organisational unit: Strategic research area

More filtering options
  1. Walking difficulties is the main contributor to fear of falling in people with Parkinson’s disease

    Maria H Nilsson, Jonasson, S. B., Beata Lindholm, Hagell, P. & Susanne Iwarsson, 2017, p. 1389.

    Research output: Contribution to conferenceAbstract

  2. What's on the Horizon: Defining Physiatry Through Rehabilitation Methodology.

    Jan Lexell, 2012, In : PM&R. 4, 5, p. 331-334

    Research output: Contribution to journalArticle

  3. What's to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?

    Dunning, C., George, S. & Brundin, P., 2013, In : Prion. 7, 1, p. 92-97

    Research output: Contribution to journalArticle

  4. Which ante mortem clinical features predict progressive supranuclear palsy pathology?

    Elisabet Englund, Nilsson, C. & for the Movement Disorder Society-Endorsed PSP Study Group, 2017 Jul 1, In : Movement Disorders. 32, 7, p. 995-1005 11 p.

    Research output: Contribution to journalReview article

  5. White adipose tissue browning in the R6/2 mouse model of Huntington's disease

    McCourt, A. C., Jakobsson, L., Sara Larsson, Cecilia Holm, Sarah Piel, Eskil Elmér & Maria Björkqvist, 2016 Aug 1, In : PLoS ONE. 11, 8, e0159870.

    Research output: Contribution to journalArticle

  6. Will FTLD-tau work for all when FTDP-17 retires?

    Emil Ygland, Maria Landqvist Waldö, Elisabet Englund, Andreas Puschmann & Nilsson, C., 2018, In : Brain : a journal of neurology. 141, 8, p. e62

    Research output: Contribution to journalArticle

  7. Wilson disease: Acute dystonia during treatment with SSRI or SNRI

    Wictor, L., Wictorin, K., Håkan Widner & Andreas Puschmann, 2016 Jan, In : Parkinsonism and Related Disorders. 22, Suppl 2, p. e140-e141

    Research output: Contribution to journalPublished meeting abstract

  8. Wirkung von Apomorphin auf nicht motorische Symptome bei Morbus Parkinson

    Honig, H., Per Odin & Chaudhuri, K. R., 2011, In : Aktuelle Neurologie. 38, Suppl. 1, p. S34-S38

    Research output: Contribution to journalReview article

  9. Workforce participation and activities in Parkinson's disease patients receiving device-aided therapy

    Sahlström, T., M. Eklund, J. Timpka, Henriksen, T., Nyholm, D. & P. Odin, 2018, In : Acta Neurologica Scandinavica. 138, 1, p. 78-84

    Research output: Contribution to journalArticle

  10. Workforce unavailability in Parkinson's disease

    Jonathan Timpka, Svensson, J., Maria H Nilsson, Pålhagen, S. E., Hagell, P. & Per Odin, 2017, In : Acta Neurologica Scandinavica. 135, 3, p. 332-338 7 p.

    Research output: Contribution to journalArticle

  11. α-Synuclein Fibril Formation and the Effects of Lipid Membranes

    Gaspar, R., 2018 Oct, Lund: Physical Chemistry, Lund University. 105 p.

    Research output: ThesisDoctoral Thesis (compilation)

  12. α-Synuclein-Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons.

    Decressac, M., Kadkhodaei, B., Mattsson, B., Laguna, A., Perlmann, T. & Anders Björklund, 2012, In : Science Translational Medicine. 4, 163, p. 163ra156

    Research output: Contribution to journalArticle

  13. α-Synuclein induced toxicity in brain stem serotonin neurons mediated by an AAV vector driven by the tryptophan hydroxylase promoter

    Wan, O. W., Shin, E., Mattsson, B., Caudal, D., Svenningsson, P. & Anders Björklund, 2016 May 23, In : Scientific Reports. 6, 26285.

    Research output: Contribution to journalArticle

  14. α-Synuclein is a Novel Microtubule Dynamase

    Cartelli, D., Aliverti, A., Barbiroli, A., Santambrogio, C., Ragg, E. M., Casagrande, F. V. M., Cantele, F., Beltramone, S., Marangon, J., De Gregorio, C., Pandini, V., Emanuele, M., Chieregatti, E., Pieraccini, S., Holmqvist, S., Bubacco, L., Roybon, L., Pezzoli, G., Grandori, R., Arnal, I. & 1 others, Cappelletti, G., 2016 Sep 15, In : Scientific Reports. 6, 33289.

    Research output: Contribution to journalArticle

  15. α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson’s disease patients

    Paslawski, W., Zareba-Paslawska, J., Zhang, X., Hölzl, K., Wadensten, H., Shariatgorji, M., Shorena Janelidze, Oskar Hansson, Forsgren, L., Andrén, P. E. & Svenningsson, P., 2019 Jul 23, In : Proceedings of the National Academy of Sciences of the United States of America. 116, 30, p. 15226-15235 10 p.

    Research output: Contribution to journalArticle

  16. α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function

    Kuan, W-L., Bennett, N., He, X., Skepper, J. N., Martynyuk, N., Wijeyekoon, R., Moghe, P. V., Williams-Gray, C. H. & Barker, R. A., 2016 Nov, In : Experimental Neurology. 285, Pt A, p. 72-81 10 p.

    Research output: Contribution to journalArticle

  17. α-Synuclein: The Long Distance Runner.

    George, S., Rey, N., Reichenbach, N., Steiner, J. & Brundin, P., 2013, In : Brain Pathology. 23, 3, p. 350-357

    Research output: Contribution to journalArticle

  18. β-amyloid Peptides and Amyloid Plaques in Alzheimer's Disease.

    Gunnar Gouras, Tomas Olsson & Oskar Hansson, 2015, In : Neurotherapeutics. 12, 1, p. 3-11

    Research output: Contribution to journalReview article

Previous 1...42 43 44 45 46 Next